Table 3. Comparison of baseline characteristics between non-survivors and survivors in patients with AE-IPF.
| Characteristics | Survivor (n=20) | Non-survivor (n=14) | P value |
|---|---|---|---|
| Men/women | 16/4 | 10/4 | 0.562 |
| Age, years (mean ± SD) | 66.40±1.56 | 69.43±1.03 | 0.150 |
| Smoking status | |||
| Never-smoker | 5 | 2 | 0.447 |
| Former smoker | 15 | 11 | 0.809 |
| Current smoker | 0 | 1 | 0.225 |
| CT visual score | |||
| GGO Score (%) | 15.00±1.65 | 20.93±2.28 | 0.038 |
| Fibrosis Score (%) | 18.86±1.18 | 25.41±1.95 | 0.003 |
| SAP130 (pg/mL) | 826.1±58.56 | 1,032±63.10 | 0.025 |
AE-IPF, acute exacerbation of idiopathic pulmonary fibrosis; GGO, ground glass opacification; SAP130, spliceosome-associated protein 130.